Response to: ‘Lower anti-drug antibodies with etanercept biosimilar: Can Ctrough explain the differences’ by Shah

Emery, P, Vencovskỳ, J, Ghil, J et al. (1 more author) (2016) Response to: ‘Lower anti-drug antibodies with etanercept biosimilar: Can Ctrough explain the differences’ by Shah. Annals of the Rheumatic Diseases, 75 (9). e61. ISSN 0003-4967

Metadata

Item Type: Article
Authors/Creators:
  • Emery, P
  • Vencovskỳ, J
  • Ghil, J
  • Kang, JW
Copyright, Publisher and Additional Information:

© 2016, BMJ Publishing Group Ltd and the European League Against Rheumatism. This is an author produced version of a paper published in Annals of the Rheumatic Diseases. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: September 2016
  • Published (online): 19 July 2016
  • Accepted: 29 June 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 01 Sep 2016 11:36
Last Modified: 13 Apr 2017 01:28
Published Version: http://dx.doi.org/10.1136/annrheumdis-2016-210114
Status: Published
Publisher: BMJ Publishing Group
Identification Number: 10.1136/annrheumdis-2016-210114
Open Archives Initiative ID (OAI ID):

Export

Statistics


CORE (COnnecting REpositories)